SYNLOGIC, INC. Operating Leases, Future Minimum Payments, Due in Three Years
SYNLOGIC, INC. (SYBX) had Operating Leases, Future Minimum Payments, Due in Three Years of $3.37 million as of 2018-12-31, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-11-12
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $3.37M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $3.27M.
- 2017-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $633.36K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $633.36K.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $3.37M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $3.27M 10-K · filed 2018-03-20 |
| 2017-03-31 | $633.36K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $633.36K 10-K · filed 2017-03-15 |
| 2016-09-30 | $614.86K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $614.86K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |